Cynor Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 98.16%
- Profit Growth 292.61%
- Ebitda -421.19%
- Net Worth 228.82%
- Total Assets 357.10%
About Cynor Pharma
Cynor Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 December 2017 (Seven years and one month 17 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amjad Ali and Manseer Yoosaf serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC303411
-
Company No.
303411
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Dec 2017
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cynor Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amjad Ali
|
Director | 28-Dec-2017 | Current |
|
Manseer Yoosaf
|
Director | 07-Apr-2022 | Current |
Financial Performance of Cynor Pharma.
Cynor Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 98.16% increase. The company also saw a substantial improvement in profitability, with a 292.61% increase in profit. The company's net worth Soared by an impressive increase of 228.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cynor Pharma?
In 2020, Cynor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Larksois Pharma Private LimitedAmjad Ali and Manseer Yoosaf are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cynor Pharma?
Unlock and access historical data on people associated with Cynor Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cynor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cynor Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
